Profil bibliographique

Boris Pasche

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

317Publications signalées

10261Citations signalées

3Affiliations récentes

Institutions déclarées

Wayne State University The Barbara Ann Karmanos Cancer Institute University of Michigan–Dearborn

Domaines associés

Pancreatic and Hepatic Oncology ResearchTGF-β signaling in diseasesGenetic factors in colorectal cancerBrain Metastases and TreatmentElectromagnetic Fields and Biological Effects

Publications récentes

Accès ouvert 2026 articleOpenAlex

Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways

Md. Hafiz Uddin, Zaid Mahdi, Irfana Muqbil, Brendon R Herring et autres

0 citationsInternational Journal of Biological Sciences

2026 articleOpenAlex

XPO1 inhibition enhances the efficacy and durability of RAS-targeted therapy in preclinical models of KRASG12D mutant pancreatic ductal adenocarcinoma

Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, Sahar F. Bannoura et autres

0 citationsCancer Letters

2026 conference-abstractOpenAlex

Abstract LB416: Targeting XPO1 reprograms immune microenvironment and confers sensitivity to immune checkpoint blockade in pancreatic ductal adenocarcinoma

Md Hafiz Uddin, Mohammed Najeeb Al Hallack, Misako Nagasaka, Sahar F. Bannoura et autres

0 citationsCancer Research

2026 conference-abstractOpenAlex

Abstract 2936: NAMPT inhibition enhances the efficacy of standard chemotherapies and immunomodulation in pancreatic ductal adenocarcinoma.

Purnachandra Nagaraju Ganji, Sujith Sarvesh, Dhana Sekhar Reddy Bandi, Husain Yar Khan et autres

0 citationsCancer Research

2026 conference-abstractOpenAlex

Abstract 5712: Virtual screening identification of FDA approved drugs blocking the therapeutic action of tumor-specific amplitude-modulated radiofrequency electromagnetic fields

Hugo Jimenez, Ping Dou, Aaban A. Azmi, Elyas Khan et autres

0 citationsCancer Research

2026 conference-abstractOpenAlex

Abstract 419: Targeting NAMPT using Novel Inhibitor RPT-E-037 in Pancreatic Neuroendocrine Tumor.

Md. Hafiz Uddin, Husain Yar Khan, Amro Aboukameel, Sahar F. Bannoura et autres

0 citationsCancer Research

2026 conference-abstractOpenAlex

Abstract 4579: Preclinical evaluation of a novel hyperbolic NAMPT inhibitor in combination with pan-RAS targeted therapies in pancreatic ductal adenocarcinoma

Husain Yar Khan, Mohammed Najeeb Al Hallak, Sahar F. Bannoura, Md. Hafiz Uddin et autres

0 citationsCancer Research

2026 conference-abstractOpenAlex

Abstract 4580: Novel PCNA inhibitor AOH1996 synergizes with KRAS-targeted therapies in pancreatic ductal adenocarcinoma

Sahar F. Bannoura, Husain Yar Khan, Md. Hafiz Uddin, Amro Aboukameel et autres

0 citationsCancer Research

Accès ouvert 2026 articleOpenAlex

TGFBR1 *6A and Risk for Colorectal Cancer

Allan M. Johansen, Julie T. Ziegler, Kojo Agyemang, Michael J. Pennison et autres

0 citations癌症：英文版

Accès ouvert 2025 preprintOpenAlex

PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer

Sahar F. Bannoura, Husain Yar Khan, Amro Aboukameel, Yin Wan et autres

1 citationbioRxiv (Cold Spring Harbor Laboratory)

Accès ouvert 2025 articleOpenAlex

Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges

Khalil Choucair, Md. Hafiz Uddin, Misako Nagasaka, Philip A. Philip et autres

39 citationsSignal Transduction and Targeted Therapy

Accès ouvert 2025 preprintOpenAlex

Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma

Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, Sahar F. Bannoura et autres

0 citationsbioRxiv (Cold Spring Harbor Laboratory)

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.